Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2423003Generated: November 3, 2026

Oxalyl chloride → 4-Chloroquinazoline

https://huagongshe.com/reaction/2423003

Reaction equation

Participants

RoleNameHCIDCharge
ReactantOxalyl chlorideHCID 65578—
Reactant4(1H)-QuinazolinoneHCID 135408753—
Product4-ChloroquinazolineHCID 78864—

Reaction Steps

The process for the preparation of Erlotinib disclosed in WO 96/30347 is shown in Scheme-1. The starting material Ethyl-3,4-dihydroxy benzoate of formula (2) is reacted with 2-bromo ethylmethyl ether in presence of a base to obtain bis-O-alkylated compound of formula (3), which is nitrated on ortho position with nitric acid in acetic acid medium to get 2-Nitro-4,5-bis(2-methoxyethoxy)benzo ate of formula (4). The nitro compound of formula (4) on hydrogenation using platinum oxide hydrate gives the amino compound of formula (5), which further reacted with ammonium formate and formamide to get 4-quinazolone compound of formula (6). The 4-quinazolone derivative is reacted with oxalyl chloride to get 4-chloro quinazoline derivative of formula (7), which on condensation with 3-ethynylaniline gives a residue containing Erlotinib base of formula (1). The residue thus obtained is purified by flash chromatography on silica to get Erlotinib base. Then the base is converted to its hydrochloride salt.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07960545B2
Source datasetuspto-grants-2011_06
ORD IDord-429862fb3fde4ae6be4e4e187952f7e7
Source noteuspto-grants-2011_06